Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Enveric Biosciences, Inc. (ENVB) had Weighted-Average Shares Outstanding (Diluted) of 0.33M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-12.13M |
|
-- |
|
-- |
|
$8.77M |
|
$-8.77M |
|
$0.00M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.77M |
|
$-8.57M |
|
0.33M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.33M |
$-36.24 |
|
$-36.24 |
|
| Balance Sheet Financials | |
$4.94M |
|
$0.16M |
|
$0.16M |
|
$5.10M |
|
$0.92M |
|
-- |
|
-- |
|
$0.92M |
|
$4.18M |
|
$4.18M |
|
$4.18M |
|
1.06M |
|
| Cash Flow Statement Financials | |
$-8.14M |
|
-- |
|
$10.58M |
|
$2.24M |
|
$4.68M |
|
$2.44M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-209.98% |
|
-209.98% |
|
-172.14% |
|
-209.98% |
|
$3.93 |
|
$-24.32 |
|
$-24.32 |
|